tiprankstipranks
Anatara Lifesciences Ltd (AU:ANR)
ASX:ANR
Australian Market

Anatara Lifesciences Ltd (ANR) Price & Analysis

Compare
0 Followers

ANR Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

3.67%96.33%
― Other Institutional Investors
96.33% Public Companies and
Individual Investors

ANR FAQ

What was Anatara Lifesciences Ltd’s price range in the past 12 months?
Anatara Lifesciences Ltd lowest share price was AU$0.02 and its highest was AU$0.07 in the past 12 months.
    What is Anatara Lifesciences Ltd’s market cap?
    Anatara Lifesciences Ltd’s market cap is AU$11.74M.
      When is Anatara Lifesciences Ltd’s upcoming earnings report date?
      Anatara Lifesciences Ltd’s upcoming earnings report date is Sep 02, 2025 which is in 192 days.
        How were Anatara Lifesciences Ltd’s earnings last quarter?
        Currently, no data Available
        Is Anatara Lifesciences Ltd overvalued?
        According to Wall Street analysts Anatara Lifesciences Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Anatara Lifesciences Ltd pay dividends?
          Anatara Lifesciences Ltd does not currently pay dividends.
          What is Anatara Lifesciences Ltd’s EPS estimate?
          Anatara Lifesciences Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Anatara Lifesciences Ltd have?
          Anatara Lifesciences Ltd has 213,383,730 shares outstanding.
            What happened to Anatara Lifesciences Ltd’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Anatara Lifesciences Ltd?
            Currently, no hedge funds are holding shares in AU:ANR
            ---

            Company Description

            Anatara Lifesciences Ltd

            Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. The company develops Detach, a natural, plant-based product that prevents and treats diarrhea in production animals. It generates its income from license revenue.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Cynata Therapeutics Limited
            Imugene Limited
            Patrys Limited
            Recce Pharmaceuticals Ltd.
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis